Overview

Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type1 Diabetes Mellitus treated with insulin.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Sanwa Kagaku Kenkyusho Co., Ltd.
Treatments:
Miglitol
Criteria
Inclusion Criteria:

- Type1 Diabetes

- Criteria of postprandial glucose and HbA1c are met

Exclusion Criteria:

- Type2 Diabetes

- Patients with antidiabetic drugs

- The other exclusion criteria are met